Seeking Alpha
22 Oct 2026, 13:50 UTC · 2h ago
Philip Morris Q3: ZYN Is Growing Again, But It's Costing More
Impact · against what's priced in
The Q3 results are largely a confirmation of existing expectations, providing no catalyst for a price move. While revenue growth remains strong, the increased marketing spend to defend ZYN offsets the gains, reinforcing the market's current hesitation to price in an acceleration of reduced-risk product margins.
- PM+0.00
Already priced in
- The price assumes
The current 41% revenue share from reduced-risk products
The report that smoke-free revenue now exceeds 40% aligns almost exactly with the 41% share the market already assumes.
What PM's price assumes · Sep 1
